MAZE NASDAQ
Maze Therapeutics, Inc.
1W: -2.6%
1M: -2.8%
3M: -41.8%
YTD: -35.2%
1Y: +154.7%
$25.78
+0.03 (+0.12%)
Weekly Expected Move ±6.1%
$22
$24
$26
$27
$29
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$20M
Revenue
+0.0% YoY
$-123M
Net Income
-273.8% YoY
$-122M
Free Cash Flow
-309.6% YoY
97.8%
Gross Margin
-132.8%
Op. Margin
-121.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-44.4%
ROA-38.4%
ROIC-291.3%
Valuation
P/E-11.3
P/B4.1
EV/EBITDA-10.2
Leverage
Debt/Equity0.07
Current Ratio15.50
Interest Cov.-148.2x
Quality Scores
Piotroski F4/9
Altman Z21.14
Beneish M0.00